Genetic Engineering of Bacteriophage K1F with Human Epidermal Growth Factor to Enhance Killing of Intracellular E. coli K1. (2023)
Attributed to:
Engineering synthetic phages against pathogenic E. coli as an innovative tool for phage therapy
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acssynbio.3c00135
PubMed Identifier: 37318278
Publication URI: http://europepmc.org/abstract/MED/37318278
Type: Journal Article/Review
Volume: 12
Parent Publication: ACS synthetic biology
Issue: 7
ISSN: 2161-5063